Psychiatry & Neurology, Neuromuscular Medicine · Orlando, FL
NPI
1225051170
Since 2006
Specialty
Psychiatry & Neurology, Neuromuscular Medicine
Code 2084N0008X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
32 W Gore St
Orlando, FL, 32806
Phone (407) 352-5434
Groups this clinician bills Medicare through
Medicare paid, 2024
$51K
3,862 services
Medicare patients, 2024
196
Average age 67
Drug cost, 2024
$5.9M
3,874 prescriptions
Company payments, 2025
$148K
From 36 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amparo Gutierrez was code 99215 (office e&m - established), 177 times for 139 patients. In total Amparo Gutierrez billed 3,862 services in 11 codes, and Medicare paid $51K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-09-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 177 | 139 | $122.18 | $22K |
| 99205 Office E&M - New | Office | 54 | 54 | $154.69 | $8,353 |
By year: 2022 $59K for 4,656 services; 2023 $52K for 3,694 services; 2024 $51K for 3,862 services.
Medicare prescription drug claims, 2024
In 2024, the drug Amparo Gutierrez prescribed most often to Medicare patients was Gabapentin, with 438 prescriptions and refills. In total Amparo Gutierrez wrote 3,874 Medicare prescriptions that cost $5.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 438 | 798 | 121 | $8,234 |
| Baclofen Generic | 332 | 673 | 107 | $7,425 |
| Duloxetine Hcl Generic | 163 | 307 | 46 | $3,913 |
| Dalfampridine Er Dalfampridine | 141 | 219 | 28 | $96K |
| Tizanidine Hcl Generic | 130 | 271 | 45 | $2,886 |
| Zolpidem Tartrate Generic | 122 | 128 | 14 | $950 |
| Topiramate Generic | 108 | 199 | 25 | $1,142 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 108 | 130 | 21 | $3,223 |
| Vumerity Diroximel Fumarate | 104 | 104 | 12 | $884K |
| Kesimpta Pen Ofatumumab | 97 | 97 | 14 | $835K |
| Modafinil Generic | 84 | 100 | 18 | $7,603 |
| Sumatriptan Succinate Generic | 76 | 92 | 22 | $832 |
| Levetiracetam Generic | 65 | 146 | 21 | $1,580 |
| Trazodone Hcl Generic | 58 | 142 | 19 | $350 |
| Escitalopram Oxalate Generic | 57 | 112 | 17 | $541 |
Brand drugs: 501 claims; generic drugs: 3,360 claims; opioid claims: 15.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amparo Gutierrez $148K ($147K in general payments such as food, travel and fees and $76.67 for research) from 36 companies. The largest payer was EMD Serono, Inc. with $51K.
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. MRK.DE | 37 | $51K |
| Biogen, Inc. BIIB | 45 | $31K |
| TG Therapeutics, Inc. TGTX | 29 | $29K |
| Ares Trading SA | 5 | $21K |
| E.R. Squibb & Sons, L.L.C. BMY | 6 | $7,663 |
| Novartis Pharmaceuticals Corporation NVS | 45 | $3,938 |
| Amgen Inc. AMGN | 17 | $607 |
| Abbvie Inc. ABBV | 19 | $415 |
| Alexion Pharmaceuticals, Inc. AZN | 7 | $387 |
| Genentech USA, Inc. ROG.SW | 22 | $332 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.